Patents by Inventor D. Mark Gapinski

D. Mark Gapinski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Leukotriene antagonists
    Patent number: 5235064
    Abstract: This invention provides benzene derivatives which are leukotriene antagonists, formulations of those derivatives, intermediates for preparing the derivatives, and a method of using those derivatives for the treatment of conditions characterized by an excessive release of leukotrienes.
    Type: Grant
    Filed: July 27, 1992
    Date of Patent: August 10, 1993
    Assignee: Eli Lilly and Company
    Inventor: D. Mark Gapinski
  • Leukotriene antagonists
    Patent number: 5171882
    Abstract: This invention provides benzene derivatives which are leukotriene antagonists, formulations of those derivatives, intermediates for preparing the derivatives, and a method of using those derivatives for the treatment of conditions characterized by an excessive release of leukotrienes.
    Type: Grant
    Filed: October 16, 1990
    Date of Patent: December 15, 1992
    Assignee: Eli Lilly and Company
    Inventor: D. Mark Gapinski
  • Leukotriene antagonists
    Patent number: 4996230
    Abstract: This invention provides tricyclic derivatives which are leukotriene B.sub.4 antagonists, formulations of those derivatives, and a method of using those derivatives for the treatment of conditions characterized by an excessive release of leukotrienes.
    Type: Grant
    Filed: February 16, 1990
    Date of Patent: February 26, 1991
    Assignee: Eli Lilly and Company
    Inventor: D. Mark Gapinski
  • Intermediates for leukotriene antagonists
    Patent number: 4992576
    Abstract: This invention provides benzene derivatives which are leukotriene antagonists, formulations of those derivatives, intermediates for preparing the derivatives, and a method of using those derivatives for the treatment of conditions characterized by an excessive release of leukotrienes.
    Type: Grant
    Filed: March 27, 1990
    Date of Patent: February 12, 1991
    Assignee: Eli Lilly and Company
    Inventor: D. Mark Gapinski
  • Diphenylmethanone compounds and anti-inflammatory use thereof
    Patent number: 4801616
    Abstract: This invention provides certain diphenylmethane derivatives, their pharmaceutical formulations, and their use in treating inflammation and arthritis in mammals.
    Type: Grant
    Filed: March 25, 1986
    Date of Patent: January 31, 1989
    Assignee: Eli Lilly and Company
    Inventor: D. Mark Gapinski